NCT Number: NCT03019861
Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling
The main goal of this randomized controlled clinical study is to evaluate the efficacy of an individual Ayurvedic nutritional counseling (according to tradition) compared to an individual conventional dietary advice (according to the German Nutrition Society - DGE) in patients with irritable bowel syndrome. It is to be investigated whether nutritional therapy elements, which patients can self-implement independently in the home environment, can achieve sustainable therapy effects.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Kliniken Essen-Mitte, Essen, Am Deimelsberg 34 A, Germany
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis "irritable bowel syndrome" according to the ROM-III criteria and the German S3 guideline (Layer 2011)
- Female and male patients between 18 and 70 years of age
- Declaration of consent
Exclusion criteria
- Bad general condition
- Serious acute or chronic comorbidity
- Pregnancy and breast feeding period
- Eating disorder
- In recognition procedures for early retirement or disability
- Simultaneous participation in another clinical trial
- Participation in a clinical trial within the last 3 months before enrollment
Treatment and study plan
Conventional nutritional counseling
BehavioralPrimary outcomes
-
Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change
Time frame: Change from IBS-SSS Baseline at 12 weeks
Secondary outcomes
-
Cohen Perceived Stress Scale (CPSS) - Change
Time frame: Change from CPSS Baseline at 4 weeks, 12 weeks and 6 months
-
Hospital Anxiety and Depression Scale (HADS-D) - Change
Time frame: Change from HADS-D Baseline at 4 weeks, 12 weeks and 6 months
-
Irritable bowel Syndrome - Quality of life (IBS-QOL) - Change
Time frame: Change from IBS-QOL Baseline at 4 weeks, 12 weeks and 6 months
-
VAS: Pain, Sleep, General bothersomeness, Expectation - Change
Time frame: Change from VAS Baseline at 4 weeks, 12 weeks and 6 months
-
Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change
Time frame: Change from IBS-SSS Baseline at 4 weeks and 6 months
Other outcomes
-
Stool analysis: Intestinal microbiome by sequencing 16S rRNA
Time frame: Baseline, 4 weeks
-
Qualitative interviews in focus groups
Time frame: Baseline, 6 months
Sponsors and collaborators
Lead sponsor
Charite University, Berlin, Germany
Other
Registry information
Official study title
Randomized Controlled Study on Ayurvedic Nutritional Counseling for Patients With Irritable Bowel Syndrome in Comparison to Conventional Nutritional Counseling
Acronym: AYURDA
Important dates
- Study start
- 2017
- Primary completion
- 2018
- Study completion
- 2019
- First posted
- Jan 13, 2017
- Registry last updated
- Aug 6, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
NCT07089420
Colitis, Colitis, Ulcerative
Salem, New Hampshire, United States
View Trial DetailsEffect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
NCT05995899
Colonic Diseases, Colonic Diseases, Functional
Boston, Massachusetts, United States
View Trial DetailsOnline, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
NCT06297785
Colonic Diseases, Colonic Diseases, Functional
Gothenburg, Sweden
View Trial DetailsRCT of VR Therapy for IBS
NCT06687616
Colonic Diseases, Colonic Diseases, Functional
Los Angeles, California, United States
View Trial Details